Why We Need Whistleblowers–One-third US Scientists Admit Unethical Research Practices

Why We Need Whistleblowers–One-third US Scientists Admit Unethical Research Practices Sat, 11 Jun 2005 Although the major focus of these AHRP Infomails has been on the deplorable misconduct by the pharmaceutical industry and government health care agencies, whenever we pointed a flashlight at academia and biomedical scientists, we raised the…

Boston Scientific Sold Defective Stints Amid Alarming Data / 22% Medical Device Follow-up Not Done – Boston Globe

Boston Scientific Sold Defective Stints Amid Alarming Data / 22% Medical Device Follow-up Not Done – Boston Globe Mon, 27 Dec 2004 Two reports in The Boston Globe raise concern defective medical devices – including cardiac stents, pacemakers and other medical devices–are proliferating the marketplace before their safety has been…

Merck Baby Vaccines Not Pure – LAT/ FDA Advisory-Crestor / Zyprexa Lawsuit charges Lilly concealed Diabetes risk

Merck Baby Vaccines Not Pure – LAT/ FDA Advisory-Crestor / Zyprexa Lawsuit charges Lilly concealed Diabetes risk Fri, 11 Mar 2005 The FDA’s failure to carry out its watchdog responsibility to protect the public from unsafe drugs, has encouraged the pharmaceutical industry to conceal the risks and deceive the public….

Prozac Revisited: Concerns About Suicides Surface – Boston Globe

Prozac Revisited: Concerns About Suicides Surface – Boston Globe Eli Lilly’s denial about the risk of suicide for some patients prescribed Prozac was the subject of a series of reports in the Boston Globe. The article (Sunday, June 11) revealed the irony behind the duplicity. Dr. Martin Teicher, who first…

2 letters Re: Dr. Nemeroff Failure to Disclose Conflicts of Interest_WSJ

Success in academic psychiatry is not measured in the improvement of patients' mental health, but rather in quantifiable commercial tender.How many grants one brings to the university, how many publications one churns out each year, and how many corporate and professional advisory boards one serves on–and how much money one…

Director Yale Psychiatric Institute concedes “I don’t think drugs can prevent full-blown psychosis”_

Our criticism of a high risk, speculative drug experiment conducted on healthy children and adolescents at Yale University’s Psychiatric Institute was validated by a federal investigation: and our criticism is now validated by the principle investigator, Dr. Thomas McGlashan.

Humbling Reality–Treatments for Depression Often Fail_Boston Globe

The Boston Globe reports (below): “More than 50 years after psychiatrists began widely dispensing drugs to treat mental illness, the profession is coming face to face with a humbling reality: Its treatments often fail, leaving millions of patients [  ] to suffer while doctors search for something that works.”